Related Experiment Video
Updated: Jul 19, 2026
07:31
Nitropeptide Profiling and Identification Illustrated by Angiotensin II
Published on: June 16, 2019
Atrial natriuretic peptide: a hormone with implications for clinical practice
1College of Nursing, Wayne State University, Detroit, MI 48201.
Heart & Lung : the Journal of Critical Care
|March 1, 1990
Summary
The heart releases atrial natriuretic peptide (ANP) to manage fluid overload. This hormone counteracts the renin-angiotensin-aldosterone system, impacting multiple organs and offering clinical potential for fluid balance management.
Area of Science:
- Endocrinology
- Cardiovascular Physiology
- Nephrology
Background:
- The heart acts as an endocrine organ, secreting atrial natriuretic peptide (ANP).
- ANP release is triggered by atrial distension due to sodium and fluid overload.
- ANP exerts significant effects across multiple organ systems.
Purpose of the Study:
- To describe the physiological effects of atrial natriuretic peptide (ANP).
- To explore the clinical implications of ANP in patient care.
- To highlight ANP's role in fluid and electrolyte balance.
Main Methods:
- Review of physiological mechanisms of ANP.
- Analysis of ANP's interaction with the renin-angiotensin-aldosterone system.
- Discussion of clinical applications and potential future uses.
Main Results:
- ANP opposes the renin-angiotensin-aldosterone system through vasorelaxation and inhibition of aldosterone and renin.
- ANP influences cardiovascular, renal, neural, gastrointestinal, and endocrine systems.
- ANP plays a crucial role in regulating fluid and electrolyte homeostasis.
Conclusions:
- ANP is a key hormone in managing fluid and electrolyte balance.
- Clinical strategies may involve modulating ANP secretion for patient treatment.
- Pharmacological administration and hematological monitoring of ANP are potential future clinical practices.
Related Concept Videos
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:17Hormonal Regulation of Blood Pressure
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...